LYKOS THERAPEUTICS for LYKOS THERAPEUTICS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Defense DEF
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Health Issues HCR
Issues related to pharmaceutical distribution (SUPPORT for Patients and Communities Reauthorization Act of 2025, H.R. 2483 / S. 2121).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Veterans VET
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.